亚洲在线日韩伦理片,96精品国产AⅤ一区二区,青鸟影视网,yy黄色频道,国内精品久久久精品AV电影院
Products
News
Resources
Contact
Language
簡體中文
繁體中文
English
日本語
???
Ti?ng Vi?t
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
2025-08-28 20:00
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
2025-08-18 20:00
LakeShore Biopharma Announces US$15 Million Private Placement Financing
2025-07-08 19:25
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA? Rabies Vaccine (Vero Cell)
2025-04-23 21:35
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
2024-12-19 22:05
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-10-29 20:30
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
2024-10-25 20:30
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
2024-10-08 20:30
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
2024-09-27 19:00
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
2024-09-10 20:00
LakeShore Biopharma Announces Leadership Transitions
2024-09-04 20:00
LakeShore Biopharma Announces Leadership Transitions
2024-09-04 20:00
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
2024-08-15 20:30
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition
2024-07-05 19:00
1